Press Release

Printer Friendly Version View printer-friendly version
<< Back
POZEN Inc. Announces Plans to Webcast Fourth-Quarter and Year-End Earnings Conference Call

CHAPEL HILL, N.C., Feb. 23 /PRNewswire/ -- POZEN Inc. (Nasdaq: POZN), a pharmaceutical development company with a portfolio of product candidates for the treatment of migraine, today announced it plans to conduct a conference call following the release of financial results for the fourth quarter and year ended December 31, 2000. The company will release earnings before the market opens on Thursday, March 1, 2001. John R. Plachetka, Pharm.D., POZEN's president and chief executive officer, and Matthew Czajkowski, chief financial officer, will host the conference call the same day at 11:00 a.m. Eastern Standard Time.

The conference call will be simulcast live on the Internet, and can be accessed by logging on to . A replay will be available at this sight, as well as on the Investor Relations section of the company's website, , for seven days.

North Carolina-based POZEN Inc. is a pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. The company's initial focus is migraine, where it has built a robust portfolio of four product candidates through a combination of innovation and in-licensing. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN."

POZEN is on the Internet at .

Matt Czajkowski
Chief Financial Officer, of POZEN
General Inquiries
Kathy Brunson of FRB Weber Shandwick

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.